🏥 治験ポータル
← 治験一覧に戻る

小児肺高血圧症における治療成績と診療実態の追跡調査

基本情報

NCT ID
NCT02610660
ステータス
完了
試験のフェーズ
-
試験タイプ
観察
目標被験者数
388
治験依頼者名
Association for Pediatric Pulmonary Hypertension

概要

The TOPP-2 registry is an international, non-interventional, prospective registry including children and adolescents newly diagnosed with pulmonary hypertension (PH) to gain further insights in the disease course and long-term outcome of PH in childhood. Patients will undergo clinical assessments and receive standard medical care, as determined by treating physicians in their daily clinical practice. The TOPP-2 registry is specifically designed to capture the variables that have been proposed as treatment goals in PePH and the reasons for changes in treatment strategy. The TOPP-2 registry uses the new clinical classification of PH as outlined at the 5th World Symposium for Pulmonary Hypertension (WSPH) in Nice 2013 and includes new characterizations for children with PH. The registry is planned and implemented under the scientific leadership of the Association for Pediatric Pulmonary Hypertension (PePH), independently from the financial sponsors. All enrolled patients will have a follow-up period of 18 months.

対象疾患

Hypertension, Pulmonary

実施施設 (2)

慶應義塾大学病院

Tokyo, Japan

東邦大学医療センター大森病院

Tokyo, Japan